Xponance, Inc. Acadia Pharmaceuticals Inc Transaction History

Xponance, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$20.78 - $31.77 $198,490 - $303,467	9,552 New	9,552 $299,000
Q2 2021 Aug 12, 2021	SELL	$19.4 - $27.42 $229,443 - $324,296	-11,827 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$25.02 - $54.99 $5,404 - $11,877	216 Added 1.86%	11,827 $305,000
Q4 2020 Feb 11, 2021	BUY	$41.04 - $56.79 $1,805 - $2,498	44 Added 0.38%	11,611 $621,000
Q3 2020 Oct 26, 2020	BUY	$36.42 - $57.0 $12,309 - $19,266	338 Added 3.01%	11,567 $477,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $440,850 - $592,105	11,229 New	11,229 $544,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.